HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshitsugu Sugimoto Selected Research

Teriparatide (Parathar)

5/2020Design of a randomized trial of teriparatide followed by alendronate: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).
1/2020Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice-Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single-Blind Randomized Study.
1/2017[Drug selection and treatment goal in osteoporosis therapy.]
1/201724-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk.
9/2015[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Medical treatment for osteoporosis].
9/2014[Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis].
7/2014The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk.
7/2014Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial.
5/2014Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide.
1/2014[Daily subcutaneous injection of teriparatide : the progress and current issues].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshitsugu Sugimoto Research Topics

Disease

81Osteoporosis
12/2021 - 04/2002
37Type 2 Diabetes Mellitus (MODY)
01/2021 - 08/2006
17Bone Resorption
07/2019 - 01/2002
16Diabetes Mellitus
04/2021 - 04/2003
16Primary Hyperparathyroidism
01/2019 - 10/2003
15Atherosclerosis
01/2018 - 04/2002
12Neoplasms (Cancer)
03/2020 - 04/2003
10Hypercalcemia (Milk Alkali Syndrome)
01/2017 - 01/2002
8Osteoporotic Fractures
11/2020 - 09/2006
8Hyperglycemia
10/2018 - 08/2006
7Body Weight (Weight, Body)
01/2021 - 01/2008
7Chronic Renal Insufficiency
07/2019 - 11/2007
7Osteomalacia
01/2017 - 06/2008
6Postmenopausal Osteoporosis
01/2022 - 01/2009
6Hypertension (High Blood Pressure)
05/2019 - 01/2008
6Hypoparathyroidism
01/2019 - 08/2007
6Secondary Hyperparathyroidism
12/2018 - 03/2004
6Bone Diseases (Bone Disease)
08/2016 - 07/2010
5Cardiovascular Diseases (Cardiovascular Disease)
05/2019 - 08/2008
5Insulin Resistance
10/2018 - 08/2006
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 11/2007
5Hypocalcemia
01/2017 - 10/2003
5Rickets (Rachitis)
01/2017 - 10/2007
5Hypophosphatemia
06/2010 - 04/2003
4Osteonecrosis (Kienbock's Disease)
09/2019 - 01/2016
4Bone Fractures (Bone Fracture)
01/2018 - 10/2006
4Vitamin D Deficiency
01/2017 - 08/2006
4Hip Fractures (Intertrochanteric Fractures)
01/2017 - 07/2002
4Hyperparathyroidism
05/2011 - 12/2005
3Inflammation (Inflammations)
10/2019 - 12/2007
3Pituitary Neoplasms (Pituitary Adenoma)
08/2019 - 10/2006
3Hypoglycemia (Reactive Hypoglycemia)
02/2019 - 01/2016
3Neoplasm Metastasis (Metastasis)
02/2019 - 07/2010
3Sarcopenia
01/2019 - 07/2014
3Diabetes Complications
09/2016 - 03/2008
3Dyslipidemias (Dyslipidemia)
05/2016 - 02/2016
3Metabolic Bone Diseases (Osteopenia)
01/2016 - 03/2008
3Oncogenic osteomalacia
06/2010 - 04/2003
3Chronic Kidney Failure (Chronic Renal Failure)
01/2010 - 11/2007
2Congenital Abnormalities (Deformity)
12/2020 - 07/2014
2Thyrotoxicosis
12/2020 - 02/2019
2Carcinogenesis
03/2020 - 03/2004
2Nausea
01/2020 - 01/2012
2Adenoma (Adenomas)
08/2019 - 04/2003

Drug/Important Bio-Agent (IBA)

22Parathyroid Hormone (Parathormone)IBA
01/2019 - 12/2002
17Glucose (Dextrose)FDA LinkGeneric
04/2021 - 01/2008
15CalciumIBA
11/2020 - 04/2003
14Vitamin DFDA LinkGeneric
11/2020 - 04/2005
14Pharmaceutical PreparationsIBA
11/2020 - 05/2005
14Teriparatide (Parathar)FDA Link
05/2020 - 09/2010
14GlucocorticoidsIBA
01/2019 - 11/2002
12Insulin (Novolin)FDA Link
07/2019 - 08/2006
12OsteocalcinIBA
12/2018 - 10/2008
11MineralsIBA
01/2018 - 06/2002
10Diphosphonates (Bisphosphonates)IBA
09/2019 - 01/2009
10Advanced Glycation End ProductsIBA
01/2019 - 08/2006
10Phosphates (Orthophosphate)IBA
01/2015 - 04/2003
9Insulin-Like Growth Factor I (IGF-1)IBA
01/2019 - 09/2002
8DenosumabFDA Link
12/2020 - 01/2011
8Risedronic Acid (Actonel)FDA LinkGeneric
01/2020 - 01/2005
7CreatinineIBA
01/2021 - 12/2009
7hydroxide ionIBA
11/2020 - 08/2006
6Hemoglobins (Hemoglobin)IBA
01/2021 - 01/2008
6Alkaline PhosphataseIBA
03/2016 - 07/2002
6SteroidsIBA
09/2014 - 08/2002
6AdiponectinIBA
10/2011 - 11/2007
5AcidsIBA
11/2020 - 01/2005
51,25-dihydroxyvitamin DIBA
01/2017 - 12/2007
5Fibroblast Growth Factor-23IBA
06/2010 - 04/2003
4Alendronate (Alendronate Sodium)FDA LinkGeneric
05/2020 - 01/2005
4HomocysteineIBA
10/2019 - 08/2015
425-hydroxyvitamin DIBA
05/2019 - 02/2014
4Calcitriol Receptors (Calcitriol Receptor)IBA
12/2018 - 04/2003
4LDL CholesterolIBA
01/2018 - 04/2002
4HDL CholesterolIBA
01/2018 - 04/2002
4Interleukin-6 (Interleukin 6)IBA
01/2017 - 01/2002
4Biomarkers (Surrogate Marker)IBA
09/2014 - 01/2009
3Raloxifene Hydrochloride (Evista)FDA Link
11/2020 - 05/2019
3elcatoninIBA
03/2020 - 04/2011
3Cholecalciferol (Vitamin D3)FDA Link
03/2019 - 11/2011
3A-factor (Streptomyces)IBA
01/2019 - 03/2008
3Vitamin K 2 (Vitamin K2)IBA
07/2017 - 06/2002
3Bone Density Conservation AgentsIBA
01/2017 - 01/2016
3oxidized low density lipoproteinIBA
02/2015 - 04/2002
3pentosidineIBA
09/2010 - 03/2008
3Hemoglobin AIBA
09/2010 - 01/2009
3Calcium-Sensing ReceptorsIBA
01/2010 - 12/2002
2Zoledronic Acid (Zometa)FDA Link
01/2022 - 12/2021
2Uric Acid (Urate)IBA
01/2021 - 01/2020
2Thyroid HormonesIBA
12/2020 - 01/2020
2TabletsIBA
01/2020 - 07/2019
2AntibodiesIBA
01/2020 - 01/2008
2Hydrocortisone (Cortisol)FDA LinkGeneric
08/2019 - 11/2016
2Collagen Type I (Type I Collagen)IBA
07/2019 - 09/2010

Therapy/Procedure

19Therapeutics
03/2020 - 08/2002
6Parathyroidectomy
08/2008 - 10/2003
5Drug Therapy (Chemotherapy)
02/2019 - 10/2008
5Renal Dialysis (Hemodialysis)
12/2018 - 07/2002
3Injections
01/2020 - 03/2013
3Glycemic Control
01/2016 - 08/2009